Published by Coherent Market Insights
Posted on September 27, 2021
4 min readLast updated: February 2, 2026
The Marek Disease Market is expanding due to increased poultry health concerns, with significant growth in North America and Asia Pacific.
“The Marek Disease Market 2021 – 2027 report covers the important factors driving the growth of the market, untapped opportunities for manufacturers, trends and developments shaping the dynamics of the market and other insights across various key segments.”
Click Here To Get Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/794
Marek disease is a highly contagious and viral neoplastic disease in chickens caused by an alphaherpesvirus known as Gallid alphaherpesvirus 2 or Marek’s disease virus. Signs and symptoms include skin around feather follicles raised and roughened, vision impairment, grey iris or irregular pupil, loss of weight, paralysis of legs, wings and neck, etc. However, there is no cure for this disease. There is only prevention and management of this disease as it spreads through chicken dander and dust, and thus, it is important to maintain a good condition within enclosures. The Marek disease market is witnessing robust growth due to the rising concerns of the disease in poultry-dense regions.
Poultry meat and eggs are among the most widely consumed animal-based foods. For instance, in 2020, the consumption of poultry meat in India was found to be over 3.9 million metric tons. Moreover, the consumption of poultry in the United States reached around 112.5 pounds per capita in 2019. The affected birds are highly susceptible to parasitic and bacterial infections. Furthermore, the high production rate of livestock, increasing foodborne diseases, increasing demand for animal protein, and increasing consumer concern over food safety are some of the factors augmenting the Marek disease market growth.
Another factors driving the Marek disease market growth include increasing prevalence of zoonotic diseases, increased shipping of poultry, high-intensity breeding, growing demand for poultry-derived food products, and rising disease outbreaks in poultry. As a result, in January 2020, Boehringer Ingelheim launched a vaccine, VAXXITEK HVT+IBD+ND, to protect poultry from three diseases, such as Marek’s Disease, Infectious Bursal Disease (classic and variant types), and Newcastle Disease. Moreover, in November 2019, Boehringer Ingelheim launched a new innovative and effective vaccine to treat the most virulent strains of Marek’s disease affecting poultry.
In North America and the Asia Pacific, the Marek disease market is witnessing robust growth due to the increasing awareness regarding animal health, large livestock population, growing demand for poultry-derived food products, growing virulence of the herpes virus, innovative research and development initiatives, and high-intensity production facilities in these regions. Moreover, market players are increasingly investing in research and development to develop safe and effective treatment for Marek disease, which, in turn, is also expected to accelerate the Marek disease market growth.
Marek disease often results in death or severe production loss in both layer and meat chickens. The disease can develop within 3 to 4 weeks in meat chickens, whereas in layers, most deaths occur between 12 and 24 weeks of age.
Top Key Players Include In Marek Disease Market: Pfizer Inc, Sanofi-Aventis U.S., Merck & Co., Inc., Virbac, and Bayer Healthcare.
The Marek Disease Market is displayed in 13 Chapters:
Chapter 1: Market Overview, Drivers, Restraints and Opportunities
Chapter 2: Market Competition by Manufacturers
Chapter 3: Production by Regions
Chapter 4: Consumption by Regions
Chapter 5: Production, By Types, Revenue and Market share by Types
Chapter 6: Consumption, By Applications, Market share (%) and Growth Rate by Applications
Chapter 7: Complete profiling and analysis of Manufacturers
Chapter 8: Manufacturing cost analysis, Raw materials analysis, Region-wise manufacturing expenses
Chapter 9: Industrial Chain, Sourcing Strategy and Downstream Buyers
Chapter 10: Marketing Strategy Analysis, Distributors/Traders
Chapter 11: Market Effect Factors Analysis
Chapter 12: Market Forecast
Chapter 13: Marek Disease Research Findings and Conclusion, Appendix, methodology and data source
Get This premium report with Instant US$ 2000 discount @ https://www.coherentmarketinsights.com/promo/buynow/794
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com
Visit Our Blog For More Such Reports: https://www.coherentmarketinsights.com/blog
The post Marek Disease Market by 2027 Manufacturers, Driving Factors, Trends, Opportunities, Technical Progress appeared first on Gatorledger.
The article discusses the growth and trends in the Marek Disease Market, a viral disease affecting poultry.
Factors include rising poultry health concerns, demand for poultry products, and vaccine development.
Key players include Pfizer Inc, Sanofi-Aventis U.S., Merck & Co., Inc., Virbac, and Bayer Healthcare.
Explore more articles in the Research Reports category
